Cargando…
Successful use of ketamine to treat severe depression with suicidality post-COVID-19 – A case report
Every second patient who suffers from COVID-19 experiences is at risk for depression. The treatment of severe depression with suicidal risk is challenging in patients with COVID-19 given the restrictions in access to and safety concerns with the use of electroconvulsive therapy during the COVID pand...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800325/ https://www.ncbi.nlm.nih.gov/pubmed/36597498 http://dx.doi.org/10.1016/j.psycr.2022.100100 |